DGX
48
11
SPG
60
2
VRSN
53
-5
KO
38
-3
KHC
9
-4
MMM
35
-5
OI
42
-3
AMGN
42
-4
HSIC
45
5
MAS
52
-4
SRE
63
2
DG
8
-2
ROP
53
-9
KLAC
38
-6
ISRG
71
-5
UAL
83
-2
PSA
56
3
HAL
48
-3
MSFT
48
-9
DTE
43
5
DGX
48
11
SPG
60
2
VRSN
53
-5
KO
38
-3
KHC
9
-4
MMM
35
-5
OI
42
-3
AMGN
42
-4
HSIC
45
5
MAS
52
-4
SRE
63
2
DG
8
-2
ROP
53
-9
KLAC
38
-6
ISRG
71
-5
UAL
83
-2
PSA
56
3
HAL
48
-3
MSFT
48
-9
DTE
43
5
Financhill
Back

iShares MSCI Norway ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
43

ENOR
iShares MSCI Norway ETF

Last Price:
23.42
Seasonality Move:
0.49%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
43
iShares MSCI Norway ETF (ENOR) is a Sell

Is iShares MSCI Norway ETF a Buy, Sell or Hold?

  • The current iShares MSCI Norway ETF [ENOR] share price is $23.74. The Score for ENOR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • ENOR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENOR Stock Price Chart

What is iShares MSCI Norway ETF's stock price today?

  • The iShares MSCI Norway ETF share price today is $23.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENOR is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ENOR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 47.23 Sell
Chaikin Money Flow: -2495 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.6 - 24.24) Sell
Bollinger Bands (100): (23.77 - 24.71) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ENOR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.57 Buy
20-day SMA: 23.85 Sell
50-day SMA: 24.15 Sell
200-day SMA: 24.09 Sell
8-day EMA: 23.6 Buy
20-day EMA: 23.81 Sell
50-day EMA: 24.06 Sell
200-day EMA: 24.08 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

iShares MSCI Norway ETF Earnings Growth & ENOR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

iShares MSCI Norway ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):